Compare Hims and Hers Health Inc (HIMS) vs Motorola Solutions Inc (MSI) Price & Performance

Hims & Hers Health trades at $29.54, up slightly by 0.24% on the day. The stock shows a bullish technical signal with moving averages supporting an uptrend, while oscillators remain neutral. Fundamentally, the company reported revenue of $2.35 billion in 2025 but swung to a net loss of $142 million in 2026, with a negative net margin of 5.51%. Analyst consensus is a 'Hold' with a price target of $32.17, but the stock faces significant headwinds from multiple securities class action lawsuits announced in early October 2026.

The outlook for HIMS is clouded by legal risks and profitability challenges despite revenue growth. Investment opportunity hinges on the company's ability to return to profitability and resolve regulatory scrutiny. Key risks include ongoing litigation, FTC complaints, and execution missteps in a competitive telehealth market. Wall Street remains cautious with 65% of analysts recommending Hold.

MSI trades at $448.48, down 1.72% on the day, amid a bearish technical signal. The company shows strong fundamentals with revenue growth to $11.68 billion in 2025 and a net income margin of 17.44%. Recent news highlights expansion in defense and public safety contracts, including a $139 million Louisiana deal and a $1.5 billion D-Fend acquisition, bolstering its security portfolio. Analyst consensus remains bullish with a $525.86 price target, though cash flow trends show significant investing outflows for growth initiatives.

The outlook for MSI is positive due to robust earnings beats, a record $15.6 billion backlog, and strategic acquisitions enhancing its market position. Risks include high valuation multiples, substantial debt levels, and execution challenges in integrating new acquisitions. Institutional confidence is evident from increased holdings and a $2 billion share repurchase authorization, supporting long-term shareholder value amid near-term cash flow pressures.